
VAM-IHCA Trial Presentation at CCR22
Critical Care Reviews Podcast
00:00
The VAMI-Ketra for in-Hospital Car Arrest
VAMI-Ketra is vasopressin and methyl prednisolone for in-hospital car arrest. The primary outcome was return of spontaneous circulation but we also looked at some key secondary outcomes including survival and a favorable neurological outcome up to one year after the cardiac arrest. We had screened 2,362 patients and excluded quite a number of patients based on different reasons. First of all there was a large number of patients who never received adrenaline. It was commonly because they had a shockable rhythm and was defibrillated out of their cardiac arrest or because the clinical team quickly recognized that CPR and further care was not indicated for them.
Transcript
Play full episode